Lipid/vascular wall interaction

Current Opinion in Cardiology

Volumn 13, Issue 6, 1998, Pages 439-446

  Allen, Sean ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOGLYCAN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; LIPID BLOOD LEVEL; LIPID OXIDATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031727038     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199811000-00009     Document Type: Review

References (71)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
2. Parthasarathy S, Steinberg D, Witztum JL: The role of oxidized low-density lipoprotein in the pathogenesis of atherosclerosis. Annu Rev Med 1992, 43:219-225.
3. Yla-Herttuala S, Rosenfield ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D: Gene expression in macrophage-rich human atherosclerotic lesions: 15 lipoxygenase and acetyl LDL receptor mRNA colocalise with oxidation-specific lipid-protein adducts. J Clin Invest 1991, 87:1146-1152.
4. Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL: The scavenger cell pathway for lipoprotein degradation: specificity of binding sites that mediate the uptake of negatively charged LDL by macrophages. J Supramol Struct 1980, 13:67-81.
5. Yla-Herttula S: Expression of lipoprotein receptors and related molecules in atherosclerotic lesions. Curr Opin Lipidol 1996, 7:292-297.
6. Brown MS, Goldstem JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983, 52:223-261.
7. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T: Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci U S A 1992, 89:9252-9256.
8. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994, 63:601-637.
9. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924.
10. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993, 364:343-346.
11. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA: The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci U S A 1986, 83:2704-2708.
12. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993, 92:471-478.
13. Shackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO: Oxidised low density lipoprotein suppresses activation of NFκB in macrophages via a pertussis toxin-sensitive signalling mechanism. J Biol Chem 1995, 270:3475-3478.
14. Brown MS, Goldstein JL: Receptor mediated control of cholesterol metabolism. Science 1976, 191:150-154.
15. Esser V, Limbird LE, Brown MS, Goldstein JL, Russell DW: Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J Biol Chem 1988, 26:13282-13290.
16. Russel DW, Brown MS, Goldstein JL: Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 1989, 264:21782-21788.
17. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ: Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985, 1:1-39.
18. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
19. Goldstein JL, Brown MS: Familial hypercholesterolemia. In The Metabolic Basis of Inherited Diseases, ed.5. Edited by Scriver CR, Beaydt AL, Sly WS, Valle D. New York:McGraw-Hill; 1989:1215-1250.
20. Fass D, Blacklow S, Kim PS, Berger JM: Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997, 388:691-693. This article provides the first molecular explanation for hypercholesterolemia by studying the x-ray crystallography images of the LDL receptor. It also questions the current theory of apolipoprotein binding to the LDL receptor, suggesting a hydrophobic concave face provides a lipoprotein-binding surface.
21. Sudhof TC, Goldstein JL, Brown MS, Russel DW: The LDL receptor gene: a mosaic of exons shared with different proteins. Science 1985, 288:815-822.
22. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
23. Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA: Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotem E. Science 1991, 252:1817-1822.
24. Innerarity TL, Pitas RE, Mahley RW: Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem 1979, 254:4186-4190.
25. Smirnov VN, Voyno-Yasenetskaya TA, Antonov AS, Lukashev ME, Shirinsky VP, Tertov VV, Tkachuk VA: Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci 1990, 598:167-181.
26. Negre-Salvaryre A, Fitoussi G, Reaud V, Pieraggi MT, Thiers JC, Salvayre R: A delayed and sustained rise of cytosolic calcium is elicited by oxidised low-density lipoprotein in cultured bovine aortic endothelial cells. FEBS Lett 1992, 299:60-65.
27. Schaefer HIMP, Hold KM, Egas-Kenniphaas JM, van der Laarse A: Intracellular calcium signalling after binding of low-density lipoprotein to confluent and non-confluent cultures of an endothelial cell line, EA.hy 926. Cell Calcium 1993, 14:507-516.
28. Smalley DM, Lin JHC, Curtis ML, Kobari Y, Stemerman MB, Pritchard KA Jr: Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 1996, 16:585-590.
29. Haller H, Schaper D, Ziegler W, Philipp S, Kuhlmann M, Distler A, Luft FC: Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension 1995, 25:511-516.
30. Allen S, Khan S, Mohanna F, Batten P, Yacoub M: Native low density lipoprotein-mduced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 1998, 101:1064-1075. This article reports the novel finding that LDL binding to the LDL receptor can trigger intraendothelial cell calcium transients that act as a second messenger to induce VCAM-1 and E-selectin expression in human vascular endothelial cells.
31. Barbir M, Lazem F, Bowker T, Ludman P, Banner N, Mitchell A, Yacoub M: Determinants of transplant-related coronary calcium detected by ultrafast computed tomography scanning. Am J Cardiol 1997, 79:1606-1609. This study explains how the new technology of ultrafast-computed tomography scanning can be used to determine the approximate calcium content of patients' atherosclerotic coronary arteries and relate it to the degree of dyslipoproteinemia.
32. Zhu Yi, Lin JHC, Liao HL, Friedli O, Verna L, Marten NW, et al.: LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998, 18:473-480. The results of this investigation show the novel finding that LDL can induce the transcription factor activating protein-1 (AP-1) in endothelial cells.
33. Genest JJ, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM, et al.: Lipoprotein cholesterol, apolipoprotein A-1 and B and lipoprotein (a) abnormality in men with premature coronary heart disease. J Am Coll Cardiol 1992, 19:792-802.
34. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982, 23:97-104.
35. Shen MMS, Krauss RM, Lindgren FT, Forte TM: Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981, 22:236-244.
36. Campos H, Blijlerens E, McNamara JR, Ordovas JM, Posner BM, Wilson PWF, et al.: Low density lipoprotein particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb 1992, 12:1410-1419.
37. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM: Differences in receptor binding of LDL subfractions. Arterioscler Thromb Vasc Biol 1996, 16:794-801.
38. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenins GR, Lupien PJ, Despres JP: Small, dense low density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec cardiovascular study. Circulation 1997, 95:69-75. The data presented in this study show that there is a correlation between the number of small dense LDL particles and increased risk of ischemic heart disease in men.
39. 2+]i in vascular smooth muscle cells. Circ Res 1993, 73:118-124.
40. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
41. Fogelman, AM, Schechter JS, Hokom M, Child JS, Edwards PA: Malondialdehyde alteration of low density lipoprotein leads to cholesterol accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A 1980, 77:2214-2218.
42. Henriksen T, Mahoney EM, Steinberg D: Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1981, 78:6499-6503.
43. Heineke JW, Rosen H, Chait A: Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1987, 74:1890-1894.
44. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, et al.: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 1987, 84:5928-5931.
45. Bjorkham I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P: The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 1991, 11:15-22.
46. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al.: An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386:73-77. This study provides evidence for the existence of a novel endothelial cell receptor for oxidized LDL.
47. Fox PL, Chisolm GM, DiCorleto PE: Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical peroxidation. J Biol Chem 1987, 262:6046-6054.
48. Hamilton TA, Ma GP, Chisolm GM: Oxidised low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J Immunol 1990, 144:2343-2350.
49. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ: Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature 1990, 344:254-257.
50. Cushing SD, Berliner JA, Valente AJ, Navab M, Demer LL, Parhami F, et al.: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990, 87:5134-5138.
51. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T: Rabbit very tow density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci U S A 1992, 89:9252-9256.
52. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, et al.: Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 1995, 270:15747-15754.
53. Battey FD, Gafvels ME, Fitzgerald DJ, Argraves WS, Chappell DA, Strauss JF III, Strickland DK: The 39-KDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem 1994, 269:23268-23273.
54. Wyne KL, Pathak RK, Seabra MC, Hobbs HH: Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 1996, 16:407-415.
55. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S: Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: Marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998, 97:1079-1086. This investigation provides evidence for increased expression of the VLDL and LDL-receptor related protein receptor in rabbit atherosclerotic lesions, which the authors say may be involved in the formation of both smooth muscle cell-derived and macrophage-derived foam cells.
56. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: an eight year follow-up in the Copenhagen male study. Circulation 1998, 97:1029-1036. These clinical trial data show that in men a high level of fasting triglycerides is a strong risk factor for coronary heart disease, independent of other major risk factors.
57. Luoma J, Hiltunen T, Sarkioja T, Moestrup SK, Gliemann J, Kodama T, et al.: Expression of α2-macroglobulin receptor low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994, 93:2014-2021.
58. Mikhailenko I, Kounnas MZ, Argraves WS, Strickland DK: Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. J Biol Chem 1995, 270:9543-9549.
59. Nykjaer A, Kjoller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld A: Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic α2-macroglobulin receptor/LDL receptor-related protein: evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J Biol Chem 1994, 269:25688-25676.
60. Orth K, Madison EL, Gething MJ, Sambrook JF, Hertz J: Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type-1 are internalized by means of the low density lipoprotein receptor-related protein/α2 macroglobulin receptor. Proc Natl Acad Sci U S A 1992, 89:7422-7426.
61. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS: Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem 1981, 256:8234-8241.
62. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM: Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988, 8:851-857.
63. Camejo G, Acquatela H, Lalaguna F: The interaction of low density lipoprotein with arterial proteoglycans: an additional risk factor? Arteriosclerosis 1980, 36:55-65.
64. Anber V, Millar JS, McConnell M, Shephard J, Packard CJ: Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol 1997, 17:2507-2514. This study shows that a number of different lipoproteins, including VLDL, LDL, and IDL, can interact with human arterial wall proteoglycans (APG), especially small dense LDL, which has a high affinity for APG, which might contribute to atherosclerosis.
65. Budde T, Fechtrup C, Bosenberg E, Vielhaver C, Enberg A, Schulte H, et al.: Plasma and Lp(a) levels correlate with number, severity, and length-extension of coronary arteriography for lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994, 14: 1730-1736.
66. Barbir M, Kushwaha S, Hunt B, Macken A, Thompson GR, Mitchell A, et al.: Lipoprotein (a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet 1992, 340:1500-1501.
67. Koschinsky ML, Cote GP, Gabel B, van der Hoek YY: Identification of the cysteine residue in apolipoprotein (a) which mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 1993, 268:19819-19825.
68. McLean JW, Tomlinson JE, Kuang W, Eaton DL, Chen EY, Fless GM, et al.: cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 330:132-137.
69. Nachman RL: Thrombosis and atherogenesis: molecular connections. Blood 1992, 79:1897-1906.
70. Loscalzo J, Weinfeld M, Fless GM, Scanu AM: Lipoprotein (a), fibrin binding and plasminogen activation. Arteriosclerosis 1990, 10:240-245.
71. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM: Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science 1993, 260:1655-1658.